These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14063746)

  • 1. THE FIBRINOLYTIC RESPONSE TO NICOTINIC ACID IN ABNORMAL LIVER STATES.
    WEINER M
    Am J Med Sci; 1963 Sep; 246():294-300. PubMed ID: 14063746
    [No Abstract]   [Full Text] [Related]  

  • 2. [INFLUENCE OF A NICOTINIC ACID DERIVATIVE ON FIBRINOLYTIC PROCESSES].
    PERICOLI F; NUZZI R
    Policlinico Prat; 1963 Nov; 70():1589-95. PubMed ID: 14115994
    [No Abstract]   [Full Text] [Related]  

  • 3. [VALUE OF THROMBELASTOGRAPHY IN THERAPEUTIC FIBRINOLYSIS OBTAINED USING A NICOTINIC ACID DERIVATIVE].
    PERRETTA A; PARANO JR; VILLA JJ
    Prensa Med Argent; 1964 Aug; 51():427-31. PubMed ID: 14193347
    [No Abstract]   [Full Text] [Related]  

  • 4. ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.
    FLETCHER AP; BIEDERMAN O; MOORE D; ALKJAERSIG N; SHERRY S
    J Clin Invest; 1964 Apr; 43(4):681-95. PubMed ID: 14149921
    [No Abstract]   [Full Text] [Related]  

  • 5. FIBRINOLYTIC BLEEDING AND ITS MANAGEMENT.
    SHERRY S; FLETCHER AP; ALKJAERSIG N
    Ann N Y Acad Sci; 1964 Jul; 115():481-92. PubMed ID: 14192857
    [No Abstract]   [Full Text] [Related]  

  • 6. [EFFECT OF INCREASED FIBRINOLYSIS ON PLASMA FIBRINOGEN; A HYPOTHESIS CONCERNING THE ORIGIN OF AFIBRINOGENEMIA].
    DE WIT CD; MOERS AM; DEN OTTOLANDERGJ
    Ned Tijdschr Geneeskd; 1964 Aug; 108():1482-5. PubMed ID: 14182799
    [No Abstract]   [Full Text] [Related]  

  • 7. [7-(3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL)-1,3-DIMETHYL-XANTHINE NICOTINATE IN ADVANCED VASCULAR DISEASES].
    FEUNEDECOLOMBI G; SCIARROTTA NO; DUSSAUT A
    Sem Med; 1963 Jul; 123():17-22. PubMed ID: 14084888
    [No Abstract]   [Full Text] [Related]  

  • 8. [BETAIN NICOTINATE IN PROLONGED ORAL FIBRINOLYTIC THERAPY].
    FRANDOLI G; GIBELLI A; TURAZZA G
    Gazz Int Med Chir; 1964 Nov; 68():2065-83. PubMed ID: 14242275
    [No Abstract]   [Full Text] [Related]  

  • 9. STUDIES WITH COMPLAMIN, A NICOTINIC-ACID-THEOPHYLLINE ESTER, AS A FIBRINOLYTIC AGENT.
    MCNICOL GP; DOUGLAS AS
    Br Med J; 1965 May; 1(5443):1149-53. PubMed ID: 14273517
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in blood coagulation and fibrinolysis systems after Hassab's procedure for portal hypertension.
    Tanaka T; Ichiba Y; Seikoh R; Takeuchi H; Itoh N; Kodama O; Dohi K
    Hiroshima J Med Sci; 1985 Sep; 34(3):351-4. PubMed ID: 4066402
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of nicotinic acid on the fibrinolytic activity of the blood in atherosclerosis].
    SHERSHEVSKII MG
    Kardiologiia; 1963; 3():64-8. PubMed ID: 13977201
    [No Abstract]   [Full Text] [Related]  

  • 12. [FIBRINOLYTIC CHEMOTHERAPY. FIRST RESULTS OF A PERSONAL EXPERIENCE].
    PERRIN A; FONTAINE L; SAINT-PIERRE A
    Lyon Med; 1964 Dec; 212():1551-60. PubMed ID: 14253644
    [No Abstract]   [Full Text] [Related]  

  • 13. 2 CASES OF FIBRINOLYSIS DURING SHUNT OPERATION IN CIRRHOSIS OF THE LIVER.
    LEIBA H; RAMOT B; MANY A
    Isr Med J; 1964; 23():176-80. PubMed ID: 14215370
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrinolytic action of nicotinic acid].
    MARRAZZA P; LUCA S
    Acta Vitaminol; 1960 Oct; 14():207-9. PubMed ID: 13767111
    [No Abstract]   [Full Text] [Related]  

  • 15. EFFECT OF NICOTINIC ACID ON FIBRINOLYTIC ACTIVITY OF THE BLOOD IN ATHEROSCLEROSIS.
    SHERSHEVSKII MG
    Fed Proc Transl Suppl; 1963; 22():1154-6. PubMed ID: 14079323
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of nicotinic acid on fibrinolytic activity in health, in thrombotic disease and in liver cirrhosis.
    Robertson BR
    Acta Chir Scand; 1971; 137(7):643-8. PubMed ID: 5149150
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations on the use of nicotinic acid to induce in vivo fibrinolytic activity.
    WILSON WL; FOSTIROPOULOS G
    Am J Med Sci; 1959 Nov; 238():591-7. PubMed ID: 13845147
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of thrombolytic activity.
    VERSTRAETE M
    Thromb Diath Haemorrh; 1961; 6(Suppl 1)():238-9. PubMed ID: 13996900
    [No Abstract]   [Full Text] [Related]  

  • 19. CONTROL OF FIBRINOLYSIS DURING PORTACAVAL SHUNTS. STUDY OF PATIENTS WITH CIRRHOSIS OF THE LIVER.
    GROSSI CE; ROUSSELOT LM; PANKE WF
    JAMA; 1964 Mar; 187():1005-8. PubMed ID: 14102935
    [No Abstract]   [Full Text] [Related]  

  • 20. Tryptophan and nicotinic acid metabolism in patients with cirrhosis of the liver.
    Gabuzda GJ; Davidson CS
    Am J Clin Nutr; 1962 Nov; 11():502-8. PubMed ID: 13946032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.